MENU
PBYI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Puma Biotechnology (PBYI) Ownership - Who owns Puma Biotechnology?

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
10880 Wilshire Boulevard
Phone
+1 424 248-6500
Employees
185
Web
http://www.pumabiotechnology.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
149.33M
P/E Ratio
4.85
Total Cash
100.97M
Projected Growth
N/A
Total Debt
74.08M
Revenue
230.47M
Risk (Beta)
1.33
Dividend Yield
N/A
Total Cash/Share
2.04
Total Debt/Equity
N/A
Revenue/Share
4.69 USD as % of share price

Fundamentals

PBYI
Capitalization
149M
P/E Ratio
4.85
Risk (Beta)
1.33
Dividend Yield
N/A
Total Cash
101M
Total Cash/Share
2.04
Total Debt
74.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.69%
Revenue
230M
ROE
N/A
Book Value
92.1M
P/B Ratio
1.62
Cash Flow
N/A
Earnings
0.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
1.54
Current Revenue Per Employee
343470.94
Dividends Per Share - Security
N/A
EBITDA
48.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
76.44
Revenue To Assets
13.64
Shares Held By Institutions
114M
Shares Outstanding - Current
49.6M
Total Liabilities
121M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-1.311
View a ticker or compare two or three
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10880 Wilshire Boulevard
Phone
+1 424 248-6500
Employees
185
Web
http://www.pumabiotechnology.com